Messchendorp et al. showed in a previous study that urinary β2M and MCP-1 excretion were both strongly associated with annual GFR decline in ADPKD after statistical adjustment for conventional risk markers [32]. The gene discussed is B2M; the disease is autosomal dominant polycystic kidney disease.